Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.41 USD | -0.93% |
|
+0.39% | +33.90% |
Jul. 16 | TD Cowen Adjusts Price Target on Boston Scientific to $86 From $77 | MT |
Jul. 16 | Truist Raises Price Target on Boston Scientific to $90 From $86, Maintains Buy Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.90% | 115B | |
+4.57% | 212B | |
+8.61% | 187B | |
+26.34% | 155B | |
+2.17% | 65.5B | |
+14.50% | 52.87B | |
-3.30% | 45.25B | |
-3.98% | 39.7B | |
+6.66% | 37.72B | |
+19.72% | 30.38B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Boston Scientific Corporation Announces Unaudited Sales Results for the Fourth Quarter and Full Year Ended December 31, 2017